Adult T-cell leukemia-lymphoma · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
LSG15 Variant #01 Partial | — | R 2 710 | 28d | — | — | — | — | — |
CHOP-14 Variant #01 | — | R 872 | 14d | — | ~10.9 mo | — | — | — |
Interferon alfa-2b and Zidovudine Variant #01 | — | R 67 | 7d | — | — | — | — | — |
mLSG15 N/A - intrathecal component | — | R 0 | 28d | — | — | — | — | — |
4 of 4 regimens shown